|
Re: NEO Compensation
|
6
|
Resverlogix Corp.
|
May 22, 2021 04:55PM
|
|
Re: New analyst coverage with a $12.50 valuation
|
4
|
Resverlogix Corp.
|
May 02, 2017 03:12AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 26, 2022 09:27PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 12:34PM
|
|
Re: New Article
|
2
|
Resverlogix Corp.
|
Dec 04, 2021 11:07AM
|
|
Re: New Frontiers for both RVX/Zenith
|
1
|
Resverlogix Corp.
|
Apr 18, 2017 11:37AM
|
|
Re: New Frontiers for both RVX/Zenith
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 06:22PM
|
|
Re: New Insider filing dated Feb 12 - Change in the nature of ownership
|
2
|
Resverlogix Corp.
|
Feb 17, 2020 02:57AM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 09, 2022 11:38AM
|
|
Re: New insights from this study -- Questions for scientists.
|
2
|
Resverlogix Corp.
|
Jun 08, 2022 03:05PM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 18, 2019 03:55PM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 18, 2019 07:43PM
|
|
Re: New MD&A posted
|
3
|
Resverlogix Corp.
|
Dec 19, 2019 02:08AM
|
|
Re: New patent application - USA Inventor
|
5
|
Resverlogix Corp.
|
May 08, 2017 04:45PM
|
|
Re: New Pfizer Antiviral Drug
|
1
|
Resverlogix Corp.
|
Nov 05, 2021 12:33PM
|
|
Re: New Pfizer Antiviral Drug
|
1
|
Resverlogix Corp.
|
Nov 05, 2021 01:08PM
|
|
Re: New Pfizer Antiviral Drug
|
1
|
Resverlogix Corp.
|
Nov 05, 2021 02:10PM
|
|
Re: New Posters Intentions and Let's get some Marketing Going for RVX
|
3
|
Resverlogix Corp.
|
May 31, 2019 12:38AM
|
|
Re: New RVX Tweet
|
4
|
Resverlogix Corp.
|
Aug 01, 2020 04:22AM
|
|
Re: New RVX Tweet
|
5
|
Resverlogix Corp.
|
Sep 04, 2020 07:38PM
|
